Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tetrahydro-3H-pyrazolo[4,3-a]phenanthridine-based CDK inhibitor.
Opoku-Temeng C , Dayal N , Hernandez DE , Naganna N , Sintim HO . Opoku-Temeng C , et al. Among authors: hernandez de. Chem Commun (Camb). 2018 May 1;54(36):4521-4524. doi: 10.1039/c8cc01154k. Chem Commun (Camb). 2018. PMID: 29629444
3H-Pyrazolo[4,3-f]quinoline-Based Kinase Inhibitors Inhibit the Proliferation of Acute Myeloid Leukemia Cells In Vivo.
Dayal N, Řezníčková E, Hernandez DE, Peřina M, Torregrosa-Allen S, Elzey BD, Škerlová J, Ajani H, Djukic S, Vojáčková V, Lepšík M, Řezáčová P, Kryštof V, Jorda R, Sintim HO. Dayal N, et al. Among authors: hernandez de. J Med Chem. 2021 Aug 12;64(15):10981-10996. doi: 10.1021/acs.jmedchem.1c00330. Epub 2021 Jul 21. J Med Chem. 2021. PMID: 34288692
3H-pyrazolo[4,3-f]quinoline hinge binder, a tunable scaffold for development of novel kinase inhibitors against FLT3-driven leukemia.
Dayal N, Řezníčková E, Hernandez DE, Peřina M, Bělíček J, Vojáčková V, Krňávková P, Bařina M, Brauer NR, Hunjan MK, Yadav P, Jorda R, Sintim HO. Dayal N, et al. Among authors: hernandez de. Eur J Med Chem. 2026 Jan 15;302(Pt 2):118309. doi: 10.1016/j.ejmech.2025.118309. Epub 2025 Oct 29. Eur J Med Chem. 2026. PMID: 41187563 Free article.
Transformation of a Potent C9-Substituted Phenylmorphan into MOR Partial Agonists with Improvement of Metabolic Stability: An In Vitro, In Vivo, and In Silico Study.
Hernandez DE, Luo D, Prisinzano TE, Negus SS, Nassehi N, Selley DE, Shah P, Kato R, Xu X, Talarico C, Graziani D, Beccari AR, Jacobson AE, Rice KC, Sulima A. Hernandez DE, et al. ACS Chem Neurosci. 2025 Jun 4;16(11):2110-2127. doi: 10.1021/acschemneuro.5c00211. Epub 2025 May 20. ACS Chem Neurosci. 2025. PMID: 40393055 Free PMC article.
97 results